Your browser doesn't support javascript.
loading
Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.
Cramer, Sarah D; Hixon, Julie A; Andrews, Caroline; Porter, Ross J; Rodrigues, Gisele O L; Wu, Xiaolin; Back, Tim; Czarra, Kelli; Michael, Helen; Cam, Maggie; Chen, Jack; Esposito, Dominic; Senkevitch, Emilee; Negi, Vijay; Aplan, Peter D; Li, Wenqing; Durum, Scott K.
Afiliação
  • Cramer SD; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Hixon JA; Department of Veterinary Medicine, University of Maryland, College Park, MD, USA.
  • Andrews C; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Porter RJ; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Rodrigues GOL; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Wu X; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK.
  • Back T; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Czarra K; Molecular Biology Laboratory, Boldrini Children's Center, Campinas, Brazil.
  • Michael H; Department of Genetics, Evolution and Bioagents, Institute of Biology, State University of Campinas, Campinas, Brazil.
  • Cam M; Genomics Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc. (LBR), Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD, USA.
  • Chen J; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Esposito D; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
  • Senkevitch E; Laboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda, MD, USA.
  • Negi V; Center for Cancer Research Collaborative Bioinformatics Resource, NCI, NIH, Bethesda, MD, USA.
  • Aplan PD; Center for Cancer Research Collaborative Bioinformatics Resource, NCI, NIH, Bethesda, MD, USA.
  • Li W; Protein Expression Laboratory/RAS Reagents Core, NCI RAS Initiative, LBR, FNLCR, Frederick, MD, USA.
  • Durum SK; Cytokines and Immunity Section, Cancer and Inflammation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD, USA.
Leukemia ; 32(8): 1795-1882, 2018 08.
Article em En | MEDLINE | ID: mdl-29535426
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Regulação Leucêmica da Expressão Gênica / Transformação Celular Neoplásica / Genes ras / Receptores de Interleucina-7 / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Mutação Limite: Animals Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Regulação Leucêmica da Expressão Gênica / Transformação Celular Neoplásica / Genes ras / Receptores de Interleucina-7 / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Mutação Limite: Animals Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos